Original language | English |
---|---|
Pages (from-to) | 3357-3359 |
Number of pages | 3 |
Journal | Blood |
Volume | 125 |
Issue number | 21 |
DOIs | |
Publication status | Published - 2015 |
Externally published | Yes |
Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/ refractory indolent lymphoma
Chan Yoon Cheah, Loretta J. Nastoupil, Sattva S. Neelapu, Sheryl G. Forbes, Yasuhiro Oki, Nathan H. Fowler
Research output: Contribution to journal › Letter
70
Citations
(Scopus)